Top Washington Pharmaceutical Startups (8)
Navigating Cancer is the leading digital health solution for oncology. We focus on improving the patient experience, delivering more effective care management, and enabling oncology care innovation.
In 1921, Guy Hollister, a chemist, and Dr. Robert Stier, a pathologist, developed a treatment to bring relief to the allergy suffering in their own families. From those beginnings a company dedicated to putting an end to allergy suffering was born, HollisterStier Allergy. Over the years that focus has not wavered, and our quest for better ways to do things...
Halo-Bio RNAi Therapeutics Inc. is an early stage company.
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies
Kirk's Pharmacy is your hometown pharmacy dedicated to providing fast, friendly, and knowledgeable service from our experienced staff.
Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune...
Selkirk is a new aseptic Fill and Finish CMO located in the healthcare hub of the Pacific Northwest, and we are focused on providing the most reliable aseptic fill and finish services available. Our facility is purpose-built for contract manufacturing with unidirectional process flows, electronic batch records and the most advanced SKAN isolators and Bausch and Stroebel filling equipment. At...
Resolve Therapeutics is a biotechnology company developing an exciting new biologic compound for the treatment of lupus that inhibits a key upstream step in the interferon cascade. The company is based on technology and compounds exclusively licensed from the University of Washington. The company will develop these compounds through early clinical testing and partner with a pharmaceutical company for late...
